share_log

Anebulo Pharmaceuticals Q1 EPS $(0.11) Down From $(0.07) YoY

Anebulo Pharmaceuticals Q1 EPS $(0.11) Down From $(0.07) YoY

AneBulo制药第一季度每股收益为0.11美元,较上年同期下降0.07美元
Benzinga Real-time News ·  2022/11/10 08:07

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.11) per share. This is a 57.14 percent decrease over losses of $(0.07) per share from the same period last year.

纳斯达克(AneBulo PharmPharmticals)公布季度每股亏损0.11美元。这比去年同期每股亏损0.07美元减少了57.14%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发